LOPALCO, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 8.304
AS - Asia 3.164
EU - Europa 2.278
SA - Sud America 811
AF - Africa 122
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 3
Totale 14.690
Nazione #
US - Stati Uniti d'America 8.173
SG - Singapore 1.493
BR - Brasile 709
CN - Cina 695
HK - Hong Kong 442
SE - Svezia 442
RU - Federazione Russa 424
IT - Italia 360
FR - Francia 269
DE - Germania 241
VN - Vietnam 193
GB - Regno Unito 176
FI - Finlandia 131
IN - India 69
CA - Canada 65
ID - Indonesia 49
MX - Messico 49
CI - Costa d'Avorio 48
AR - Argentina 44
JP - Giappone 39
ZA - Sudafrica 35
ES - Italia 34
BD - Bangladesh 33
BE - Belgio 32
IQ - Iraq 31
TR - Turchia 26
PL - Polonia 25
AT - Austria 23
CZ - Repubblica Ceca 21
UA - Ucraina 19
LT - Lituania 18
EC - Ecuador 17
NL - Olanda 17
PK - Pakistan 15
IE - Irlanda 14
UZ - Uzbekistan 12
IR - Iran 10
PY - Paraguay 10
VE - Venezuela 10
MA - Marocco 9
CO - Colombia 8
KE - Kenya 8
EU - Europa 7
SA - Arabia Saudita 7
AM - Armenia 6
NP - Nepal 6
HR - Croazia 5
JO - Giordania 5
KZ - Kazakistan 5
CH - Svizzera 4
EG - Egitto 4
KG - Kirghizistan 4
NI - Nicaragua 4
PE - Perù 4
TN - Tunisia 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
BB - Barbados 3
CL - Cile 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
PH - Filippine 3
QA - Qatar 3
RO - Romania 3
SN - Senegal 3
AU - Australia 2
CR - Costa Rica 2
DK - Danimarca 2
GE - Georgia 2
HN - Honduras 2
IL - Israele 2
LU - Lussemburgo 2
ML - Mali 2
PT - Portogallo 2
RS - Serbia 2
SI - Slovenia 2
AF - Afghanistan, Repubblica islamica di 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GF - Guiana Francese 1
GH - Ghana 1
GI - Gibilterra 1
HU - Ungheria 1
IS - Islanda 1
JM - Giamaica 1
LB - Libano 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
MM - Myanmar 1
MN - Mongolia 1
MW - Malawi 1
NO - Norvegia 1
NR - Nauru 1
Totale 14.682
Città #
Fairfield 1.068
Ashburn 939
Singapore 762
Woodbridge 692
Houston 651
Chandler 574
Seattle 444
Hong Kong 438
Ann Arbor 390
Cambridge 387
Nyköping 364
Wilmington 329
Beijing 296
Dallas 202
Los Angeles 139
New York 131
Lawrence 125
Roxbury 120
Munich 112
Bari 105
Jacksonville 85
Des Moines 78
Nanjing 77
Buffalo 70
São Paulo 68
Moscow 65
Ho Chi Minh City 64
Inglewood 64
Princeton 57
Santa Clara 51
Brooklyn 50
Abidjan 48
London 47
San Diego 45
Turku 42
Helsinki 37
Shenyang 35
Jakarta 34
Paris 34
Tokyo 33
Brussels 32
Chicago 32
Hanoi 32
Dearborn 28
Johannesburg 27
Belo Horizonte 25
Dong Ket 23
Milan 23
Boston 22
Denver 22
Rio de Janeiro 22
San Francisco 22
Toronto 22
Warsaw 22
Council Bluffs 21
Nanchang 20
Mexico City 19
Brasília 18
The Dalles 18
Columbus 17
Frankfurt am Main 17
Montreal 17
Poplar 17
Chennai 16
Jiaxing 16
Pune 16
Atlanta 15
Manchester 15
Phoenix 15
Redwood City 15
Stockholm 15
Boardman 14
Dublin 14
Tianjin 14
Changsha 13
Guangzhou 13
Hebei 13
Falkenstein 12
Campinas 11
San Mateo 11
Tashkent 11
Vienna 11
Augusta 10
Brno 10
Goiânia 10
Nuremberg 10
Orem 10
Salt Lake City 10
Shanghai 10
Baghdad 9
Curitiba 9
Da Nang 9
Dhaka 9
Giovinazzo 9
Taranto 9
Chaozhou 8
Charlotte 8
Dongguan 8
Guarulhos 8
Ankara 7
Totale 10.293
Nome #
Safety of Long-Term Biologic Therapy in Rheumatologic Patients With a Previously Resolved Hepatitis B Viral Infection 183
Sarcopenia in Patients with Rheumatic Diseases: Prevalence and Associated Risk Factors 174
Correlation between serum amyloid-A and serum levels of proinflammatory cytokines in patients with Behçet's disease 164
AB0065 Possible Interplay Between Serum Amyloid-A and Pro-Inflammatory Cytokines Into the Pathogenesis of Behçet's Disease 163
AB0836 Drug retention rate of the first tnf inhibitor in radiographic and non radiographic axial spondyloarthritis: data from a multicenter study 162
A Bayesian mixed treatment comparison of efficacy of biologics and small molecules in early rheumatoid arthritis 157
Efficacy and safety profile of anti-interleukin-1 treatment in Behçet’s disease: a multicenter retrospective study 155
A false occult hepatitis B virus infection developed in a patient with psoriatic arthritis under infliximab and methotrexate therapy 154
Retinal vessels thrombosis as onset manifestation of systemic sclerosis: 3 clinical cases 153
Adalimumab Accounts for Long-Term Control of Noninfectious Uveitis Also in the Absence of Concomitant DMARD Treatment: A Multicenter Retrospective Study 153
Basic characteristics of adults with periodic fever, aphthous stomatitis, pharyngitis, and adenopathy syndrome in comparison with the typical pediatric expression of disease 152
AB0452 Changes in Lipoproteins Associated with Tocilizumab Treatment Do not Influence the Atherogenic Index of Plasma of Rheumatoid Arthritis Patients: Table 1 152
Mucocutaneous Involvement in Behçet's Disease: How Systemic Treatment Has Changed in the Last Decades and Future Perspectives 144
AB0041 Serum Amyloid A Stimulates The Induction of Inflammatory Mediators in Monocytes from Behçet's Disease Patients: A Proof of Concept Study 144
Refractory knee giant cell tumor of the synovial membrane treated with intra-articular injection of Infliximab: A case series and review of the literature 140
Autoimmunity and autoinflammation as the yin and yang of idiopathic recurrent acute pericarditis 140
Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: Premises, perils, and perspectives 139
Different switching rate of anti-TNF-α drugs in monotherapy and in combination with methotrexate in a cohort of rheumatoid arthritis patients in the real life 138
Unveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory Diseases 138
Effectiveness and tuberculosis-related safety profile of interleukin-1 blocking agents in the management of Behçet's disease 137
Interleukin (IL)-1 inhibition with anakinra and canakinumab in Behçet's disease-related uveitis: a multicenter retrospective observational study 137
AB0369 Adult-onset still’s disease treatment predictors at 1-year follow-up in a single rheumatologic centre experience 137
SAT0216 Chest Ultrasound Signs of Interstitial Lung Disease in Systemic Sclerosis Patients: A Comparison between High Resolution Chest Computed Tomography Findings 137
Cumulative retention rate of adalimumab in patients with Behçet's disease-related uveitis: a four-year follow-up study 136
Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients 134
A comprehensive comparison between pediatric and adult patients with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenopathy (PFAPA) syndrome 132
Auditory involvement in Behcet’s disease: relationship with demographic, clinical, and therapeutic characteristics 132
Paradoxical mucocutaneous flare in a case of Behçet’s disease treated with tocilizumab 131
PFAPA syndrome and Behçet’s disease: a comparison of two medical entities based on the clinical interviews performed by three different specialists 129
Serum amyloid-A in Behçet's disease 128
Lipids and atherogenic indices fluctuation in rheumatoid arthritis patients on long-term tocilizumab treatment 127
Ten-Year Retention Rate of Infliximab in Patients with Behçet's Disease-Related Uveitis 125
THU0153 The effect of 5-years b-dmards treatment on different 10-years cardiovascular risk scores applied in rheumatoid arthritispatients 125
Management of Small Vessel Vasculitides 124
SAT0212 Pericardial Effusion Related To Systemic Sclerosis: A Possible Contribution of The Serum Levels of Adipokines and Interleukines 124
Proinflammatory cytokines and antiskin autoantibodies in patients with inherited epidermolysis bullosa 123
Tumor necrosis factor receptor-associated periodic syndrome managed with the couple canakinumab-alendronate 121
Untangling the web of systemic autoinflammatory diseases 121
FRI0110 Methotrexate monotherapy in real life: a drug survival analysis. comparison between very early arthritis and early arthritis cohorts 119
Key facts and hot spots on tumor necrosis factor receptor-associated periodic syndrome 118
Efficacy and safety of adalimumab in Behçet's disease-related uveitis: a multicenter retrospective observational study. 116
Certolizumab Pegol treatment in Behcet's disease with different organ involvement: A multicenter retrospective observational study 116
Longterm clinical outcomes in 420 patients with psoriatic arthritis taking anti-tumor necrosis factor drugs in real-world settings 114
AB0245 PREDICTORS OF BIOLOGIC THERAPY DISCONTINUATION IN RHEUMATOID ARTHRITIS PATIENTS AFTER REMISSION ACHIEVEMENT: A MONOCENTRIC OBSERVATIONAL STUDY FROM BIOLOGIC APULIAN REGISTRY (BIOPURE) 110
OP0129 Drug survival on anti-tnf-alpha in psoriatic arthritis patients with axial involvement and analysis of predictors 108
Systemic Steroid Sparing Effect of Intravitreal Dexamethasone Implant in Chronic Noninfectious Uveitic Macular Edema 108
Splenic Infarction as Only Manifestation of Antiphospholipid Syndrome in a Patient With Rheumatoid Arthritis 107
Efficacy of adalimumab and infliximab in recalcitrant retinal vasculitis inadequately responsive to other immunomodulatory therapies 106
Long-term retention rate of anakinra in adult onset Still’s disease and predictive factors for treatment response 106
Relapsing Polychondritis: an Update on Pathogenesis, Clinical Features, Diagnostic Tools, and Therapeutic Perspectives 105
A convolutional neural network with transfer learning for automatic discrimination between low and high-grade synovitis: a pilot study 104
Different roles of TNF inhibitors in acute anterior uveitis associated with ankylosing spondylitis: state of the art 104
Improvement of Refractory Dysphagia in Patients with Idiopathic Inflammatory Myopathies Receveing Immunoglobulin Intravenous Therapy 103
Critical regulation of Th17 cell differentiation by serum amyloid-A signalling in Behcet's disease 101
Anakinra for corticosteroid-dependent and colchicine-resistant pericarditis: The IRAP (International Registry of Anakinra for Pericarditis) study 101
THU0168 Relationships between body fat composition assessed with bioelectrical impedance analysis, serum adipokines and disease activity in patients with rheumatoid arthritis 100
The protean ocular involvement in monogenic autoinflammatory diseases: state of the art 100
Behçet's syndrome in Italy: a detailed retrospective analysis of 396 cases seen in 3 tertiary referral clinics 99
Pain Processing and Vegetative Dysfunction in Fibromyalgia: A Study by Sympathetic Skin Response and Laser Evoked Potentials 98
Long-term retention rates of adalimumab and infliximab in non-infectious intermediate, posterior, and panuveitis 98
Influence of baseline modified Rheumatic Disease Comorbidity Index (mRDCI) on drug survival and effectiveness of biological treatment in patients affected with Rheumatoid arthritis, Spondyloarthritis and Psoriatic arthritis in real-world settings 96
The role of biosimilars in uveitis: Long-term real-world outcomes of the switch from original to biosimilar TNF-alpha inhibitors 96
Explainable artificial intelligence for microbiome data analysis in colorectal cancer biomarker identification 95
SAT0380 FIBROMYALGIA IS THE STRONGEST NEGATIVE PREDICTOR FOR THE ACHIEVEMENT OF EITHER REMISSION AND MINIMAL DISEASE ACTIVITY IN NAIVE PSORIATIC ARTHRITIS PATIENTS STARTING BIOLOGIC DRUGS 95
IL-6 blockade in the management of non-infectious uveitis 93
improvement of refractory dysphagia in patients with idiopathic inflammatory myopathies receveing immunoglubulin intravenous therapy 93
The autoinflammatory side of recurrent pericarditis: Enlightening the pathogenesis for a more rational treatment 91
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study 90
Safety profile of biologic agents for Behçet's disease in a multicenter observational cohort study 88
Predictors of sustained clinical response in patients with Behçet’s disease-related uveitis treated with infliximab and adalimumab 87
null 86
Long-term safety of anti-TNF agents on the liver of patients with spondyloarthritis and potential occult hepatitis B viral infection: an observational multicentre study 86
Different drug survival of first line tumour necrosis factor inhibitors in radiographic and non-radiographic axial spondyloarthritis: a multicentre retrospective survey 86
Efficacy and safety of certolizumab pegol and golimumab in the treatment of non-infectious uveitis 85
Anakinra effectiveness in refractory polyserositis: An Italian multicenter study 82
Biological therapies for the treatment of Behçet’s disease-related uveitis beyond TNF-alpha blockade: a narrative review 82
null 82
Adalimumab effectively controls both anterior and posterior noninfectious uveitis associated with systemic inflammatory diseases: focus on Behçet’s syndrome 82
Development and Implementation of the AIDA International Registry for Patients with Non-Infectious Scleritis 82
A Machine Learning Approach to Predict Remission in Patients With Psoriatic Arthritis on Treatment With Secukinumab 81
null 81
null 80
Heterogeneous clinical spectrum of interstitial lung disease in patients with anti-EJ anti-synthetase syndrome: a case series 80
Putative role of serum amyloid-A and proinflammatory cytokines as biomarkers for behcet's disease 79
Efficacy of baricitinib on refractory skin papulosquamous rash in a patient with systemic lupus erythematosus 79
High disease relapse after bDMARD spacing in psoriatic arthritis compared to rheumatoid arthritis and axial spondyloarthritis patients: real-life data from BIOPURE registry 79
Immunogenicity of BNT162b2 mRNA SARS-CoV-2 vaccine in patients with psoriatic arthritis on TNF inhibitors 78
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study 78
Influence of changes in cholesterol levels and disease activity on the 10 years cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients 76
null 75
Complete Hydatidiform Mole Mimicking Sacroiliitis 75
Epidemiological profile of non-infectious uveitis from the rheumatologist's perspective: a survey from two tertiary referral centres in Italy 73
null 72
null 72
null 71
Effectiveness and safety profile of anakinra in a HLA-B27 positive patient with multiple sclerosis-associated uveitis 71
Development and Implementation of the AIDA International Registry for Patients with Non-Infectious Uveitis 71
null 70
Tomographic regression of pulmonary rheumatoid nodules under baricitinib therapy 70
Real-world effectiveness of apremilast in multirefractory mucosal involvement of Behçet's disease 70
Totale 10.964
Categoria #
all - tutte 71.779
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.779


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021868 0 0 0 0 0 142 140 133 121 142 99 91
2021/2022985 73 40 20 42 40 82 67 53 72 81 120 295
2022/20231.547 219 199 128 123 114 241 34 198 207 12 51 21
2023/2024545 41 107 24 44 48 129 18 28 6 15 13 72
2024/20252.950 66 37 197 64 47 279 318 347 151 201 439 804
2025/20263.933 908 311 466 969 1.174 105 0 0 0 0 0 0
Totale 15.621